Local directors in Bradford, having discussed the Elstree protocols, did not want interim heat-treated product that would only likely be available two or three months and preferred to wait until April when "a better product is promised" Read more about Local directors in Bradford, having discussed the Elstree protocols, did not want interim heat-treated product that would only likely be available two or three months and preferred to wait until April when "a better product is promised"
In a Blood Transfusion Services meeting on 4th December 1984 it was said, theoretically, "heat-treated material was likely to be safer than non-treated material" Read more about In a Blood Transfusion Services meeting on 4th December 1984 it was said, theoretically, "heat-treated material was likely to be safer than non-treated material"
In Bradford, in 1983, no cryoprecipitate was used for the treatment of patients with Haemophilia A; all treatment was with concentrates (NHS, Factorate and Kryobulin) Read more about In Bradford, in 1983, no cryoprecipitate was used for the treatment of patients with Haemophilia A; all treatment was with concentrates (NHS, Factorate and Kryobulin)
In Bradford, in 1982, there was a move away from the use of cryoprecipitate to factor concentrates and the introduction of home treatment Read more about In Bradford, in 1982, there was a move away from the use of cryoprecipitate to factor concentrates and the introduction of home treatment
In December 1984, Oxford Haemophilia Centre placed its first order for heat-treated concentrates Read more about In December 1984, Oxford Haemophilia Centre placed its first order for heat-treated concentrates
The individual patient data shows people being treated with NHS and commercial concentrate and with more than one type of commercial concentrate. Read more about The individual patient data shows people being treated with NHS and commercial concentrate and with more than one type of commercial concentrate.
In 1984 there were almost no cryoprecipitate; 1,919,162 units of NHS Factor 8; and 3,907,595 units of commercial concentrates. Read more about In 1984 there were almost no cryoprecipitate; 1,919,162 units of NHS Factor 8; and 3,907,595 units of commercial concentrates.
There was almost no cryoprecipitate used for the treatment of Haemophilia A. 1,636,580 units of NHS Factor 8 were used; over 4.5 million units of commercial concentrates were used. Read more about There was almost no cryoprecipitate used for the treatment of Haemophilia A. 1,636,580 units of NHS Factor 8 were used; over 4.5 million units of commercial concentrates were used.
Dr Rizza was in support of plans to set up an AIDS screening programme. The terms in which he wrote are instructive: "it is important that we act quickly to set up screening tests to detect the patients who might be at risk of developing the full blown condition." Read more about Dr Rizza was in support of plans to set up an AIDS screening programme. The terms in which he wrote are instructive: "it is important that we act quickly to set up screening tests to detect the patients who might be at risk of developing the full blown condition."
Cardiff's Annual Return for 1984 recorded an increase in the use of cryoprecipitate, a greater increase in the amount of NHS concentrates used (1,704,313 units), and a reduction in the amount of commercial concentrates (861,677 units). The individual patient data filed with the 1984 return showed the treatment of a child born in 1971 with cryoprecipitate. The individual patient data filed with the 1984 return showed the treatment of a child born in 1983 with cryoprecipitate. Read more about Cardiff's Annual Return for 1984 recorded an increase in the use of cryoprecipitate, a greater increase in the amount of NHS concentrates used (1,704,313 units), and a reduction in the amount of commercial concentrates (861,677 units). The individual patient data filed with the 1984 return showed the treatment of a child born in 1971 with cryoprecipitate. The individual patient data filed with the 1984 return showed the treatment of a child born in 1983 with cryoprecipitate.